FDA warns against off-label use of ketoconazole oral tablets

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1604卷 / 1期

关键词：

D O I：

10.1007/s40278-016-18059-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] FDA warns against off-label use of antipsychotic drugs
Huntzinger, A
AMERICAN FAMILY PHYSICIAN, 2005, 71 (11) : 2205 - 2205
[2] FDA recommends against off-label sildenafil use in children
Reactions Weekly, 2012, 1418 (1) : 2 - 2
[3] FDA warns against ketoconazole use in drug interaction studies
Reactions Weekly, 2013, 1475 (1) : 2 - 2
[4] Ketoconazole/MetyraponeHepatotoxicity and off-label use: case report
Reactions Weekly, 2024, 2032 (1) : 228 - 228
[5] Eisai warns of toxin spread with off-label use of Neurobloc
Reactions Weekly, 2013, 1442 (1) : 2 - 2
[6] Oral medicine: Off-label cream use
S. Porter
V. Mercadante
S. Fedele
British Dental Journal, 2014, 217 : 660 - 661
[7] ORAL MEDICINE Off-label cream use
Porter, S.
Mercadante, V.
Fedele, S.
BRITISH DENTAL JOURNAL, 2014, 217 (12) : 660 - 661
[8] FDA warns of serious hematologic reactions with off-label use of quinine sulfate for night-time leg cramps
不详
FORMULARY, 2010, 45 (08) : 264 - 264
[9] Regulating off-label drug use - Rethinking the role of the FDA
Stafford, Randall S.
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14): : 1427 - 1429
[10] FDA SCRUTINIZES OFF-LABEL PROMOTIONS
RANDALL, T
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (01): : 11 - 11

← 1 2 3 4 5 →